Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
Part of paid clinical trials in Cities in Alabama, Alabama.
- Sponsor
- AstraZeneca
- Study ID
- NCT00073177
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Roflumilast — DRUG
Study Details
The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
Key Dates
- Start date
- Nov 30, 2003
- Status verified
- Sep 2016
Study Design
- Enrollment
- 819 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
change in lung function from baseline to final visit.
Locations (37)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ALTANA Pharma | Cities in Alabama | Alabama | - | - |
| ALTANA Pharma | Cities in Arizona | Arizona | - | - |
| ALTANA Pharma | Cities in Arkansas | Arkansas | - | - |
| ALTANA Pharma | Cities in California | California | - | - |
| ALTANA Pharma | Cities in Colorado | Colorado | - | - |
| ALTANA Pharma | Cities in Florida | Florida | - | - |
| ALTANA Pharma | Cities in Georgia | Georgia | - | - |
| ALTANA Pharma | Cities in Idaho | Idaho | - | - |
| ALTANA Pharma | Cities in Illinois | Illinois | - | - |
| ALTANA Pharma | Cities in Indiana | Indiana | - | - |
| ALTANA Pharma | Cities in Iowa | Iowa | - | - |
| ALTANA Pharma | Cities in Kansas | Kansas | - | - |
| ALTANA Pharma | Cities in Kentucky | Kentucky | - | - |
| ALTANA Pharma | Cities in Louisiana | Louisiana | - | - |
| ALTANA Pharma | Cities in Maryland | Maryland | - | - |
| ALTANA Pharma | Massachusetts | Massachusetts | - | - |
| ALTANA Pharma | Cities in Michigan | Michigan | - | - |
| ALTANA Pharma | Cities in Minnesota | Minnesota | - | - |
| ALTANA Pharma | Cities in Mississippi | Mississippi | - | - |
| ALTANA Pharma | Cities in Missouri | Missouri | - | - |
| ALTANA Pharma | Cities in Montana | Montana | - | - |
| ALTANA Pharma | Cities in Nebraska | Nebraska | - | - |
| ALTANA Pharma | Cities in Nevada | Nevada | - | - |
| ALTANA Pharma | Cities in New Jersey | New Jersey | - | - |
| ALTANA Pharma | Cities in New York | New York | - | - |
| ALTANA Pharma | Cities in North Carolina | North Carolina | - | - |
| ALTANA Pharma | Cities in North Dakota | North Dakota | - | - |
| ALTANA Pharma | Cities in Oregon | Oregon | - | - |
| ALTANA Pharma | Cities in Pennsylvania | Pennsylvania | - | - |
| ALTANA Pharma | Cities in Rhode Island | Rhode Island | - | - |
| ALTANA Pharma | Cities in South Carolina | South Carolina | - | - |
| ALTANA Pharma | Cities in Tennessee | Tennessee | - | - |
| ALTANA Pharma | Cities in Texas | Texas | - | - |
| ALTANA Pharma | Cities in Utah | Utah | - | - |
| ALTANA Pharma | Cities in Virginia | Virginia | - | - |
| ALTANA Pharma | Cities in Washington | Washington | - | - |
| ALTANA Pharma | Cities in Wisconsin | Wisconsin | - | - |
Find similar trials in Cities in Alabama, AL
By condition
By specialty
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Personalized Environment and Genes StudyRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Chapel Hill, North Carolina
- Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting · Gelb, Arthur F., M.D. · Lakewood, California
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts